Skip to main content

What the FDA labels say about taking them together

Nortriptyline and propafenone

Nortriptyline's FDA label of December 4, 2024 names propafenone in its drug interactions section; propafenone's label does not name nortriptyline itself but warns about its class (Tricyclic antidepressants).

Check it at the source: the nortriptyline FDA label on DailyMed (effective December 4, 2024); the propafenone FDA label on DailyMed (effective September 1, 2025, Strides Pharma Science Limited).

What does the nortriptyline label say about propafenone?

Nortriptyline label, drug interactions

The drugs that inhibit cytochrome P450 2D6 include some that are not metabolized by the enzyme (quinidine; cimetidine) and many that are substrates for P450 2D6 (many other antidepressants, phenothiazines, and the Type 1C antiarrhythmics propafenone and flecainide).

Source: FDA drug label (PAMELOR), SpecGx LLC, effective December 4, 2024 (SPL set e17dc299-f52d-414d-ab6e-e809bd6f8acb), via openFDA; the full label on DailyMed

What does the propafenone label say about nortriptyline?

Propafenone's label does not name nortriptyline itself; it warns about its class (Tricyclic antidepressants):

Propafenone label, warnings and precautions

Such drugs may include many antiarrhythmics, some phenothiazines, tricyclic antidepressants, and oral macrolides.

Source: FDA drug label (PROPAFENONE HYDROCHLORIDE), Strides Pharma Science Limited, effective September 1, 2025 (SPL set c65253ab-937f-4982-b841-69c2b9f9ccdb), via openFDA; the full label on DailyMed

These are the labels' own sentences. PlainMeds does not grade interactions; a pharmacist or prescriber can say what they mean for one person's medicines.

Both medicines on the record

25Nortriptyline generic labelers
14Propafenone generic labelers
NortriptylinePropafenone
Labeled forDepressionAtrial fibrillation
Boxed warningYesYes
Pharmacy cost (NADAC)$0.113 per capsule 10 mg capsule$0.115 per tablet 150 mg tablet
Shortage nowNo current entryNo current entry

Source: FDA NDC Directory, CMS NADAC of October 7, 2026 and the FDA Drug Shortage Database (FDA files October 8, 2026)

What next?